Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Significantly Worsens the Lipid Profile in a Real-World Setting

Kai Juhani Kauppinen; Pia Kivelä; Jussi Sutinen

doi:10.1089/apc.2019.0236

Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Significantly Worsens the Lipid Profile in a Real-World Setting

Kai Juhani Kauppinen, Pia Kivelä, Jussi Sutinen

Research output: Contribution to journal › Article › Scientific › peer-review

Original language	English
Journal	AIDS Patient Care and STDs
Volume	33
Issue number	12
Pages (from-to)	500-506
Number of pages	7
ISSN	1087-2914
DOIs	https://doi.org/10.1089/apc.2019.0236
Publication status	Published - Dec 2019
MoE publication type	A1 Journal article-refereed

Fields of Science

HIV
tenofovir disoproxil fumarate
tenofovir alafenamide
dyslipidemia
cholesterol
lipid-lowering effect
STATIN THERAPY
DOUBLE-BLIND
MYOCARDIAL-INFARCTION
LDL CHOLESTEROL
ADVERSE EVENTS
EZETIMIBE
EFFICACY
RISK
SAFETY
3142 Public health care science, environmental and occupational health
3121 Internal medicine

Access to Document

10.1089/apc.2019.0236

Cite this

@article{392cc8c8954e456ea79f02b5f6b1b9c0,

title = "Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Significantly Worsens the Lipid Profile in a Real-World Setting",

keywords = "HIV, tenofovir disoproxil fumarate, tenofovir alafenamide, dyslipidemia, cholesterol, lipid-lowering effect, STATIN THERAPY, DOUBLE-BLIND, MYOCARDIAL-INFARCTION, LDL CHOLESTEROL, ADVERSE EVENTS, EZETIMIBE, EFFICACY, RISK, SAFETY, 3142 Public health care science, environmental and occupational health, 3121 Internal medicine",

author = "Kauppinen, {Kai Juhani} and Pia Kivel{\"a} and Jussi Sutinen",

year = "2019",

month = dec,

doi = "10.1089/apc.2019.0236",

language = "English",

volume = "33",

pages = "500--506",

journal = "AIDS Patient Care and STDs",

issn = "1087-2914",

publisher = "Mary Ann Liebert",

number = "12",

}

TY - JOUR

T1 - Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Significantly Worsens the Lipid Profile in a Real-World Setting

AU - Kauppinen, Kai Juhani

AU - Kivelä, Pia

AU - Sutinen, Jussi

PY - 2019/12

Y1 - 2019/12

KW - HIV

KW - tenofovir disoproxil fumarate

KW - tenofovir alafenamide

KW - dyslipidemia

KW - cholesterol

KW - lipid-lowering effect

KW - STATIN THERAPY

KW - DOUBLE-BLIND

KW - MYOCARDIAL-INFARCTION

KW - LDL CHOLESTEROL

KW - ADVERSE EVENTS

KW - EZETIMIBE

KW - EFFICACY

KW - RISK

KW - SAFETY

KW - 3142 Public health care science, environmental and occupational health

KW - 3121 Internal medicine

U2 - 10.1089/apc.2019.0236

DO - 10.1089/apc.2019.0236

M3 - Article

VL - 33

SP - 500

EP - 506

JO - AIDS Patient Care and STDs

JF - AIDS Patient Care and STDs

SN - 1087-2914

IS - 12

ER -